loading

Bridgebio Pharma Inc Stock (BBIO) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
11,999%
211.12
1.745 4.091 1.641 1.826
Cost Of Revenue
0.00%
0.598
0.598 0.598 0.599 0.651
Gross Profit
18,254%
210.52
1.147 3.493 1.042 1.175
Operating Expenses
17.71%
210.18
178.56 161.19 147.14 127.99
Interest Income/Expense
15.80%
23.47
20.27 20.31 20.59 20.12
Benefits Costs and Expenses
43.71%
247.28
172.07 183.58 162.34 144.56
Costs And Expenses
17.65%
210.78
179.16 161.78 147.74 127.99
Operating Income/Loss
100.19%
0.343
-177.42 -157.69 -146.10 -126.16
Nonoperating Income/Loss
615.00%
-36.50
7.088 -21.80 -14.60 -16.57
Income/Loss From Continuing Operations Before Tax
78.77%
-36.16
-170.33 -179.49 -160.70 -142.73
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
78.77%
-36.16
-170.33 -179.49 -160.70 -142.73
Net Income/Loss
78.77%
-36.16
-170.33 -179.49 -160.70 -142.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
56.70%
-0.944
-2.18 -2.489 -2.804 -2.576
Basic Average Shares
4,482%
178.71
3.9004 163.31 160.54 152.65
Diluted Average Shares
4,482%
178.71
3.9004 163.31 160.54 152.65
Basic Earnings Per Share
79.17%
-0.20
-0.96 -1.08 -0.98 -0.92
Diluted Earnings Per Share
79.17%
-0.20
-0.96 -1.08 -0.98 -0.92
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):